Intended for medicinal chemists, pharmaceutical scientists, pharmacologists, immunologists, biochemists and microbiologists, this book provides both a broad overview of the current methodologies being applied to drug design and in-depth analyses of progress in specific fields. It offers state-of-the-art approaches to pharmaceutical development, including biological technologies currently used by some of the world's foremost laboratories. Features include: discussion of new techniques; previously unpublished data; and extensive reference lists.
Intended for medicinal chemists, pharmaceutical scientists, pharmacologists, immunologists, biochemists and microbiologists, this book provides both a broad overview of the current methodologies being applied to drug design and in-depth analyses of progress in specific fields. It offers state-of-the-art approaches to pharmaceutical development, including biological technologies currently used by some of the world's foremost laboratories. Features include: discussion of new techniques; previously unpublished data; and extensive reference lists.
1. Identifying Lead Peptides from Epitope Libraries 2. Interleukin-1 Receptor Pathway Approaches to Drug Design 3. The Hematopoietic Colony-Stimulating Factors 4. Monoclonal Antibodies: Technical Development and Therapeutic Indications 5. T Cell Receptor-Based Therapy of Autoimmune Diseases 6. Oligosaccharide Pharmaceuticals 7. Gene Therapy 8. Antisense Deoxynucleotides and Ribozymes: Mechanisms of Action and Potential in Gene Therapy
David B. Weiner (University of Pennsylvania, Philadelphia, USA) (Edited by) , William V. Williams (University of Pennsylvania School of Medicine, Philadelphia,) (Edited by)
Ask a Question About this Product More... |